Why is Hester Bios falling/rising?

As of 19-Sep, Hester Biosciences Ltd is experiencing a decline in its stock price, currently at 2,004.00, reflecting a decrease of 35.0 points or 1.72%. The stock has underperformed its sector by 1.99% today and has been on a downward trend for the last three days, accumulating a total loss of 2.81%. Over the past week, the stock has decreased by 3.28%, while its performance over the year-to-date shows a significant decline of 16.24%. Despite the company reporting very positive results with a 145.1% growth in net profit and maintaining a low debt-equity ratio, the recent price movement suggests that investor participation is waning, as indicated by a 64.93% drop in delivery volume compared to the five-day average.
In the broader market context, the Sensex has shown a positive return of 0.88% over the past week, contrasting with Hester Bios' negative performance. While the stock has outperformed the benchmark over the past month with a return of 3.57% compared to the Sensex's 1.20%, the year-to-date and one-year returns indicate a significant underperformance relative to the market. This divergence highlights a troubling trend for Hester Bios, as it struggles to maintain investor interest despite strong financial results, suggesting that broader market dynamics may be influencing its stock price negatively.